Expanding on these findings, a study on hepatocytes treated with palmitic acid, an in vitro fatty liver disease model, revealed a decrease in nuclear TFEB levels and its downstream target genes encoding for lysosomal CTSB and LAMP1. Here, TFEB is linked to fatty liver disease.